Business Context and Reporting Period
This Form 8-K was filed by Graybug Vision, Inc. (not Calcimedica, Inc., as noted in the metadata) on February 9, 2023, reporting events occurring on February 5, 2023. The filing details corporate governance changes in connection with a pending Merger Agreement between Graybug Vision, Inc. and CalciMedica, Inc., originally filed on November 22, 2022.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and board composition changes.
Material Changes
The primary material change is the restructuring of the Board of Directors contingent upon the closing of the merger with CalciMedica, Inc.:
- Director Resignations: Christy Shaffer, Christina Ackermann, Julie Eastland, and Dirk Sauer resigned as directors and committee members.
- Director Appointments: A. Rachel Leheny, Eric W. Roberts, Robert N. Wilson, Fred Middleton, and Allan Shaw were appointed to the Board.
- Re-appointment: Eric Bjerkholt resigned as a Class II director and was re-appointed as a Class I director.
- Board Leadership: Robert N. Wilson will serve as the Chair of the Board.
Outlook, Risks, and Management Commentary
Management confirmed there are no disagreements between the departing directors and the Company or the Board. The new board structure is organized into three staggered classes with terms expiring in 2023, 2024, and 2025. Committee assignments were also redefined:
- Audit Committee: Eric Bjerkholt (Chair), Fred Middleton, Allan Shaw.
- Compensation Committee: Allan Shaw (Chair), Fred Middleton, Robert N. Wilson.
- Governance Committee: Robert N. Wilson (Chair), Allan Shaw.
Key Facts for Investor Verification
- Verify the closing status of the Merger Agreement between Graybug Vision, Inc. and CalciMedica, Inc., as all board changes are contingent upon this event.
- Confirm the effective date of the new board composition relative to the merger closing.
- Note that the registrant is Graybug Vision, Inc. (Ticker: GRAY), not Calcimedica, Inc.
- Review the specific staggered class terms for the new directors to understand future election cycles.